WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13341$23.95
$8.17kSell
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13430$25.42
$10.93kSell
Anthony S. MarucciPRESIDENT CEO2024-11-1111,500$26.82
$308.43kBuy

1 of 1

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas S. Paluck11.50%7,632,346$190.35MInsider
Blackrock Inc8.36%5,550,016$138.42MInstitution
Vanguard Group Inc5.96%3,957,122$98.69MInstitution
Medarex Inc4.46%2,960,848$73.84MInsider
Geode Capital Management LLC2.52%1,672,980$41.72MInstitution
Pictet Asset Management Holding Sa1.96%1,300,329$32.43MInstitution
Una S. Ryan1.35%899,213$22.43MInsider
Fisher Asset Management LLC1.24%822,208$20.51MInstitution
American Century Companies Inc1.17%779,985$19.45MInstitution
Northern Trust Corp0.87%575,875$14.36MInstitution

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX29.48%19.16%Net Buying
IMCR18.39%4.33%Net Buying
COGT22.68%11.49%Net BuyingNet Buying
TVTX41.92%58.08%Net SellingNet Selling
AUPH19.72%12.63%Net BuyingNet Buying
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 29.48% institutional shareholders, 19.16% Celldex Therapeutics insiders, and 51.37% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 11.50% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $190.35M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.